We are looking for recovery in 2Q & 2H22 in elective surgery cases in the U.S., says David Toung, Sr. Analyst, Health Care, Argus Research. He discusses the stocks of Stryker (SYK), Intuitive Surgical (ISRG), Johnson & Johnson (JNJ). Our favorites include biotech stocks that have advanced programs and strong cash on balance sheets, says Laura Chico, SVP, Equity Research, Biotechnology, Wedbush Securities. Wedbush top picks are Karuna Therapeutics (KRTX) and Chinook Therapeutics (KDNY). David also likes Thermo Fisher (TMO). Tune in for the details of why these stocks are their favorites.
Trading 360
11 Apr 2022
SHARE
Trading 360
13 Jan 2023
Morning Trade Live
18 Jan 2023
Trading 360
03 Apr 2023
The Watch List
25 Jan 2023
Market On Close
24 Feb 2023
Market On Close
28 Mar 2023